ADMA Biologics, Inc. (ADMA)
20.39
+0.41
(+2.05%)
USD |
NASDAQ |
Dec 11, 16:00
20.39
0.00 (0.00%)
After-Hours: 18:22
ADMA Biologics Free Cash Flow: 40.61M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Vanda Pharmaceuticals, Inc. | -82.95M |
| Aldeyra Therapeutics, Inc. | -40.08M |
| Arcutis Biotherapeutics, Inc. | -48.24M |
| Exelixis, Inc. | 779.77M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 13.29M |
| Cash from Investing (Quarterly) | -14.37M |
| Cash from Financing (Quarterly) | -27.82M |
| Free Cash Flow Per Share (Quarterly) | -0.0044 |
| Free Cash Flow to Equity (Quarterly) | -0.373M |
| Free Cash Flow to Firm (Quarterly) | 0.2092M |
| Free Cash Flow Yield | 0.81% |